Molecular Biology

Application IPr*Pd(acac)Cl is a palladium NHC precatalyst for a variety of cross-couplng reactions, including C-N bond formation. Other Notes [Pd(IPr*)(acac)Cl]: An easily synthesized, bulky precatalyst for C-N bond formation

Application i Pr-NDI is a ligand that when mixed with NiBr 2 , generates an active dinuclear Ni catalyst. The catalyst has been shown to promote a variety of transformations including the cyclopropanation of alkenes and the [4+1] cycloaddition of

Application iPr-PDI is a perylene based organic photocatalyst with a variety of demonstrated uses, including the reduction of aryl halides and the iodoperfluoroalkylation of alkenes. Product can be used with our line of photoreactors : Including

Application iPr-PDI is a perylene based organic photocatalyst with a variety of demonstrated uses, including the reduction of aryl halides and the iodoperfluoroalkylation of alkenes. Product can be used with our line of photoreactors : Including

HOST SPECIES: Rabbit CLONALITY: Polyclonal TESTED APPLICATIONS: E, WB, IHC-P, IF APPLICATIONS: Ipr1 antibody can be used for detection of Ipr1 by Western blot at 0.5 - 2 &#956g/mL.

HOST SPECIES: Rabbit CLONALITY: Polyclonal TESTED APPLICATIONS: E, WB APPLICATIONS: Ipr1 antibody can be used for detection of Ipr1 by Western blot at 1 - 2 &#956g/mL. Antibody validated: Western Blot in human samples.

A cell-permeable tetrahydroisoquinolinylidene compound that modulates Wnt/&#946-catenin signaling by targeting the PR72/130 subunit of PP2A and thereby blocking PP2A/Nkd complex formation, resulting in diminished &#946-catenin/p300 interaction

Application IRAK-1/4 inhibitor I has been used in various studies to inhibit IRAK1 in hepatoma cell lines and head and neck squamous cell carcinoma (HNSCC) cell lines. Biochem/physiol Actions IRAK-1/4 Inhibitor I is a novel benzimidazole that is a

Application IRAK-1/4 inhibitor I has been used in various studies to inhibit IRAK1 in hepatoma cell lines and head and neck squamous cell carcinoma (HNSCC) cell lines. Biochem/physiol Actions IRAK-1/4 Inhibitor I is a novel benzimidazole that is a

N-terminal 6His-tagged, recombinant, human IRAK1 amino acids 194-end. Product Source: Human IRAK1 expressed by baculovirus in Sf21 cells.

Biochem/physiol Actions IRAK2 (interleukin-1 receptor-associated kinase 2) belongs to the IRAK family and is ubiquitously expressed. The protein contains an amino terminal death domain and a central kinase domain.

N-terminal His6-tagged, recombinant full length, human IRAK4 Product Source: Expressed by baculovirus in Sf21 insect cells Application Research Category Inflammation &amp Immunology Biochem/physiol Actions Protein Target: IRAK4 Target Sub-Family: